Citation

Hahn MP. J. Pain Palliat. Care Pharmacother. 2012; 26(1): 30-39.

Affiliation

Michael P. Hahn, BS RT, is with Respiratory Care, Loma Linda University Children's Hospital, Loma Linda, California, USA.

Copyright

(Copyright © 2012, Informa - Taylor and Francis Group)

DOI

10.3109/15360288.2011.650353

PMID

22448939

Abstract

Palliative sedation evolved from within the practice of palliative medicine and has become adopted by other areas of medicine, such as within intensive care practice. Clinician's usually come across this practice for dying patients who are foregoing or having life support terminated. A number of intolerable and intractable symptom burdens can occur during the end of life period that may require the use of palliative sedation. Furthermore, when patients receive palliative sedation, the continued use of hydration and nutrition becomes an issue of consideration and there are contentious bioethical issues involved in using or withholding these life-sustaining provisions. A general understanding of biomedical ethics helps prevent abuse in the practice of palliative sedation. Various sedative drugs can be employed in the provision of palliative sedation that can produce any desired effect, from light sedation to complete unconsciousness. Although there are some similarities in the pharmacotherapy of palliative sedation, euthanasia, physician-assisted suicide, and lethal injection, there is a difference in how the drugs are administered with each practice. There are some published guidelines about how palliative sedation should be practiced, but currently there is not any universally accepted standard of practice.

Language: en